Follow Us:
PARS‑TRODAT is a sterile, non‑pyrogen lyophilized radiopharmaceutical kit designed for the preparation of 99mTc‑Trodat for SPECT brain imaging. Each vial contains 33 µg of Trodat as a sterile, non‑pyrogen lyophilized powder, and after radiolabeling, it is used for intravenous administration. This radiopharmaceutical binds to the dopamine transporter (DAT) in the striatum, enabling assessment of dopaminergic neuron function. Reduced uptake is typically indicative of dopaminergic neuron degeneration, a condition observed in Parkinson’s disease.
99mTc‑Trodat binds to the dopamine transporter (DAT) located at the presynaptic nerve terminals of the striatum. In neurodegenerative disorders, the number of these transporters is significantly reduced. The binding of this radiopharmaceutical to DAT enables visual assessment of the integrity and health of the dopaminergic system, helping the physician to provide a more accurate diagnosis.
Trodat (33 µg)
Stannous Chloride Dihydrate
Tricine
Mannitol


